NERV
Minerva Neurosciences Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website minervaneurosciences.com
- Employees(FY) 9
- ISIN US6033802058
Performance
+0.4%
1W
+0.8%
1M
-69.96%
3M
-50.1%
6M
-59.02%
YTD
-58.76%
1Y
Profile
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Technical Analysis of NERV 2024-05-10
Overview:
In analyzing the technical indicators for NERV over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...
Recent News & Updates
- 2024-05-06 00:00
- 2024-05-01 01:53
- 2024-04-30 19:43
Minerva Neurosciences: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-04-30 19:30
- 2024-02-26 19:11
- 2024-02-26 19:00
- 2024-02-26 17:31
Minerva schizophrenia drug rejected by FDA(Yahoo Finance)
- 2024-02-21 18:41
Minerva Neurosciences: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-02-21 18:00
- 2023-11-06 18:47
Minerva Neurosciences: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-11-06 18:30
- 2023-10-20 01:22
12 Best Performing Biotech Stocks in 2023(Yahoo Finance)
- 2023-07-31 19:40
Minerva Neurosciences: Q2 Earnings Snapshot(Yahoo Finance)
- 2023-07-31 19:30
- 2023-06-27 20:30
- 2023-06-08 21:55
- 2023-05-18 00:00
What Makes Minerva Neurosciences (NERV) a New Buy Stock(Yahoo Finance)
- 2023-05-15 09:57
Q1 2023 Minerva Neurosciences Inc Earnings Call(Yahoo Finance)
- 2023-05-14 19:40
Minerva Neurosciences: Q1 Earnings Snapshot(Yahoo Finance)
- 2023-05-14 19:30
- 2023-05-09 20:00
- 2023-05-07 20:30
- 2023-04-30 19:00
- 2023-03-09 13:24
- 2023-03-08 10:12
Q4 2022 Minerva Neurosciences Inc Earnings Call(Yahoo Finance)
- 2023-03-07 18:30
- 2023-02-28 19:30
- 2022-12-28 21:18
- 2022-12-28 16:30
- 2022-12-27 19:00
Page 1 of 4
previousnext